Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Alleviant ALLAY-HFrEF Study

NCT: NCT06812533 · ENROLLING_BY_INVITATION

NCT IDNCT06812533
StatusENROLLING_BY_INVITATION
Start Date2025-03-10
Completion2028-12

Brief Summary

Prospective, multicenter, randomized, sham-controlled, double blind (patient and observer), study designed to evaluate the safety and efficacy of a percutaneously created interatrial shunt using the Alleviant ALV1 System in patients with HFrEF.

Frequently Asked Questions

What is Alleviant ALLAY-HFrEF Study?

Alleviant ALLAY-HFrEF Study is a clinical trial registered under NCT06812533. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT06812533?

The current status of NCT06812533 (Alleviant ALLAY-HFrEF Study) is: ENROLLING_BY_INVITATION.

When did Alleviant ALLAY-HFrEF Study start?

Alleviant ALLAY-HFrEF Study started on 2025-03-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.